Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, they provide technology and services to support patient care and make every person’s story count.

Flatiron Health

Flatiron Health’s mission is to improve and extend lives by learning from the experience of every person with cancer. 

Aaron Levie

LabCorp

Google Ventures

First Round Capital

Casdin Capital

Roche

Stripes

Allen & Company

Baillie Gifford

Our Flatiron Japan team was at JSMO 2024 co-presenting research with the National Cancer Center Hospital East (NCCHE) and Eri Tajima spoke to our approach for creation of #RWD to promote its utilization in Japan at the Presidential Symposium “Infrastructure development for utilization of Real World Data.” 

In 2021, we partnered with NCCHE to build a comprehensive cancer treatment and outcomes database, and began providing the first ex-US datasets in the end of 2023. We are now further expanding our international partner network.  

Discover the significance of this initiative and its impact on cancer treatment outcomes. https://flatiron.co.jp/ 

The Flatiron #ClinicalResearch team left this year's #SCOPESummit with many insights into the way the clinical research industry is advancing through collaboration and innovation, including:

✨ #AI can, and is, having an impact on clinical research

🔬 Diversity in trials is about finding more diverse patients, but designing inclusive trials from the start

💾 The industry is shifting towards streamlined and pragmatic approaches to clinical trials

Read more ⬇ 

Today, members of the Flatiron Germany team presented at the German Cancer Congress 2024 #DKK in Berlin including an e-poster in collaboration with the University Hospital Essen.

The team's research was focused on the characteristics and outcomes of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with Lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting.

If you would like to learn more about how we are transforming oncology research and care in Germany together and how you too can become a Flatiron clinical or practice partner, please get in touch: https://flatiron.de/

Stephanie Reisinger, SVP and GM of Real-World Evidence, recently sat down with The Evidence Base® to discuss the current state and potential future of real-world evidence. 

Having more than twenty years of experience in the RWE landscape and healthcare data, Steph outlines how integration of RWD is evolving and more importantly the impact this can have on patients, healthcare providers, researchers and the broader health system. 

Read more now ⬇️
https://lnkd.in/evMHJ92H

We’re looking forward to joining other key players in oncology at the ACCC 50th Annual Meeting & Cancer Business Summit where we plan to deep dive into our latest innovations with #AI and #precisionmedicine in point of care solutions. 

Stop by our booth or join us at one of our onsite events: 

Deep Dive: EHR Integration -A Key Component of Precision Medicine
🗓️Thursday, February 29, 10:00 AM – 12:00 PM
👨‍🔬Nate Wade, PharmD, MBA, BCOP

Deep Dive: Artificial Intelligence and Business Intelligence
🗓️Thursday, February 29, 1:00 PM – 3:00 PM
👨‍🔬James Hamrick, MD, MPH, Stephen Speicher, M.D., M.S., Will Shapiro

Connect with our team to schedule time onsite at #AMCCBS24: https://lnkd.in/e5TAdxBd

COM:FLATIRON

Flatiron Health

Financials Not Available